Portfolio
 |
Aileron Therapeutics Developing a breakthrough proprietary peptide technology platform: stapled peptides convert a broad range of therapeutically useful peptides into pharmaceutically tractable molecules. |
 |
Braeburn Pharmaceuticals Braeburn Pharmaceuticals, an Apple Tree Partners company, develops and commercializes innovative medical products. Upon approval, the company's first product will be Probuphine®, a buprenorphine implant currently under FDA priority review for the maintenance treatment of opioid dependence. Braeburn's executive team has decades of experience successfully bringing blockbuster pharmaceuticals and medical devices to market, as well as a deep understanding of clinical development and quality assurance processes. |
 |
HeartWare The world-leader in miniaturized left ventricular assist devices. |
 |
Tokai Pharmaceuticals Developing the leading clinical prostate cancer molecule, with three independent mechanisms of action to suppress the disease. |